COMPARATIVE STUDY OF COAGULATION AND VASCULAR DISEASE
Project Number5R01HL009902-25
Contact PI/Project LeaderDODDS, WINIFRED J
Awardee OrganizationNYSDOH/HEALTH RESEARCH, INC.
Description
Abstract Text
Colonies of animals with inherited coagulation and platelet
function defects are maintained for genetic, biochemical and
physiological studies; production of reagents for coagulation tests;
and evaluation of hemostasis. These include dogs with hemophilia
A, hemophilia B, von Willebrand's disease (VWD), factor VII
deficiency, warfarin hypersensitivity, thrombasthenic
thrombopathia, thrombopathia and various combinations of these
defects,; fawn-hooded rats with platelet storage pool disease,
spontaneous glomerulosclerosis and hypertension; and Syrian
hamsters with age-associated spontaneous atrial thrombosis.
Studies with these naturally occurring animal models examine
basic mechanisms of hemostasis and thrombosis in comparison to
analogous human diseases.
The objectives for the next period include continuing to diagnose,
characterize, maintain and research animal models of spontaneous
hemorrhagic and thrombotic diseases; studies by in vitro and in
vivo methods of factor VIII in normal, hemophilic and VWD dogs;
studies of the platelet function defect of basset hounds;
collaboration with other investigators in research projects;
provision of reagents, genetic material and other animal products
based on their availability; consultation about the comparative
aspects of hemostasis research and bleeding disorders; ad
provision of space for visiting scientists or laboratory personnel.
Specific aims for the period include: refinement of a multimeric
assay for canine von Willebrand's factor (VWF) for diagnostic and
biochemical studies; research with rDNA-derived human factor
VIII in hemophilic and VWD dogs; studies of the molecular and
functional properties of canine VWF and factor VIII coagulant in
thyroid disease; and platelet studies focused on definition of the
biochemical defect of canine thrombopathia, specifically its
abnormal signal-response coupling via the cyclic nucleotide,
phosphodiesterase and calmodulin pathways. Screening tests for
thrombopathia using whole blood and platelet agonists and the
snake-venom-induced agglutination assay for canine plasma VWF
are used in the field for diagnostic purposes.
No Sub Projects information available for 5R01HL009902-25
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HL009902-25
Patents
No Patents information available for 5R01HL009902-25
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HL009902-25
Clinical Studies
No Clinical Studies information available for 5R01HL009902-25
News and More
Related News Releases
No news release information available for 5R01HL009902-25
History
No Historical information available for 5R01HL009902-25
Similar Projects
No Similar Projects information available for 5R01HL009902-25